Potential AstraZeneca-Bristol Myers Squibb Mega-Merger

Health & Climate Pulse

Talks to create ~$400B pharma giant. Analyst cites cost-cutting, defensive consolidation against Lilly's trillion-dollar valuation, and permissive antitrust environment. Would reshape industry landscape.

Sources (3)

Updated Aug 4, 2026

Health & Climate Pulse

Pharmaceutical Executive Daily: AstraZeneca and Bristol Myers Squibb Held Merger Talks

AstraZeneca ‘in talks to create £300bn pharmaceutical giant’

AstraZeneca, Bristol Myers Squibb in Merger Talks to Create Nearly $400 Billion Pharma Giant